ストックスクリーナーアプリを入手
10.47
3.68%
-0.40
前日終値:
$10.87
開ける：
$10.99
24時間の取引高:
1.07M
Relative Volume:
0.76
時価総額：
$1.11B
収益：
-
当期純損益:
$-258.08M
株価収益率:
-3.8073
EPS:
-2.75
ネットキャッシュフロー:
$-202.32M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+3.05%
6か月 パフォーマンス:
-47.65%
1年 パフォーマンス:
-63.31%
1日の値動き範囲:
$10.42
$11.08
1週間の範囲:
$10.42
$11.11
52週間の値動き範囲:
$9.33
$31.47
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
名前
Rocket Pharmaceuticals Inc
セクター
電話
646-440-9100
住所
350 FIFTH AVENUE, NEW YORK, NY
RCKT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
10.47 | 1.11B | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-30 | 開始されました | Wedbush | Outperform |
| 2024-12-18 | 開始されました | Jefferies | Buy |
| 2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-04-02 | 開始されました | Goldman | Neutral |
| 2023-10-24 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-02-01 | 開始されました | Morgan Stanley | Overweight |
| 2022-11-08 | 開始されました | Canaccord Genuity | Buy |
| 2022-11-01 | 開始されました | BTIG Research | Buy |
| 2022-07-08 | 開始されました | Raymond James | Outperform |
| 2021-10-20 | 再開されました | Cowen | Outperform |
| 2021-03-02 | 開始されました | Stifel | Buy |
| 2021-02-18 | 開始されました | Needham | Buy |
| 2020-12-16 | 開始されました | UBS | Buy |
| 2020-12-08 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-07-02 | 開始されました | JP Morgan | Overweight |
| 2020-06-25 | 再開されました | BofA/Merrill | Buy |
| 2020-06-01 | 再開されました | Oppenheimer | Outperform |
| 2019-11-06 | 開始されました | Chardan Capital Markets | Buy |
| 2019-09-26 | 開始されました | Piper Jaffray | Overweight |
| 2019-04-23 | 開始されました | Robert W. Baird | Outperform |
| 2019-03-15 | 開始されました | BofA/Merrill | Buy |
| 2019-02-05 | 開始されました | Oppenheimer | Outperform |
| 2018-09-13 | 開始されました | Ladenburg Thalmann | Buy |
| 2018-07-10 | 開始されました | William Blair | Outperform |
すべてを表示
Rocket Pharmaceuticals Inc (RCKT) 最新ニュース
Rocket Pharmaceuticals (RCKT) Projected to Post Quarterly Earnings on Monday - Defense World
Long Term Trading Analysis for (RCKT) - Stock Traders Daily
2 Soaring Stocks to Hold for the Next 20 Years - The Globe and Mail
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Rocket Pharmaceuticals (NASDAQ:RCKT) Hits New 52-Week LowHere's Why - MarketBeat
Sovran Advisors LLC Acquires New Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
RCKT stock touches 52-week low at $9.76 amid market challenges - MSN
Strategic Financial Concepts LLC Takes Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharma Is A Buy At These Prices With Promising Data (NASDAQ:RCKT) - Seeking Alpha
Jennison Associates LLC Purchases 29,564 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
It makes sense and dollars to buy Rocket Pharmaceuticals Inc (RCKT) stock - SETE News
(RCKT) Long Term Investment Analysis - Stock Traders Daily
Rocket Pharmaceuticals Inc (RCKT) Shares Plummet Below 1-Year High - The News Heater
What was Rocket Pharmaceuticals Inc (RCKT)’s performance in the last session? - US Post News
Holdings of Rocket Pharmaceuticals Inc (RCKT) are aligned with the stars - SETE News
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Purchased by SG Americas Securities LLC - MarketBeat
SG Americas Securities LLC Acquires 48,793 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals appoints new board member By Investing.com - Investing.com Nigeria
Rocket Pharmaceuticals appoints new board member - Investing.com
Rocket Pharmaceuticals, Inc. Announces Board Changes -January 28, 2025 at 06:03 am EST - Marketscreener.com
Rocket Pharmaceuticals vice president sells $9,300 in stock - MSN
(RCKT) Technical Pivots with Risk Controls - Stock Traders Daily
Rocket Pharmaceuticals vice president sells $9,300 in stock By Investing.com - Investing.com Australia
Leerink Partnrs Has Strong Forecast for RCKT FY2024 Earnings - Defense World
FY2024 Earnings Estimate for RCKT Issued By Leerink Partnrs - MarketBeat
Analysts Offer Predictions for RCKT FY2025 Earnings - Defense World
Cantor Fitzgerald Predicts RCKT FY2025 Earnings - MarketBeat
Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 52-Week LowHere's What Happened - MarketBeat
Analysts Set Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Price Target at $47.27 - MarketBeat
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Hexcel (NYSE:HXL) Reports Sales Below Analyst Estimates In Q4 Earnings - The Globe and Mail
RCKT stock touches 52-week low at $10.11 amid market challenges - MSN
Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 12-Month Low – Time to Sell? - Defense World
Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Down 4%Here's Why - MarketBeat
How to Take Advantage of moves in (RCKT) - Stock Traders Daily
Rocket Pharmaceuticals (RCKT) Loses -12.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - MSN
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Acquired by Mirador Capital Partners LP - MarketBeat
Rocket Pharmaceuticals Inc (RCKT) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):